Haleon PLC Reg. Shares (ADRs) o.N.
- BID
8.5
- ASK
8.6
- 2,235 Units2,814 Units
- 07/23, 14:04:59 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
4.91%
Market Cap
-
P/E Ratio
20.67
Dividend Yield
1.81 %
Earnings per Share
0.43 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 8.5 G | 0 Units |
| PRICE DETERMINATION TIME | 07/23/2026 / 01:31:35 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 8.5 | 8.3 |
| PREV. DAY'S PRICE | 8.55 | (07/22) |
| CHANGE DAY BEFORE | -0.05 | -0.58 % |
| 52 WEEK HIGH / LOW | 9.55 (02/18) | 7.25 (06/03) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.26 | 0.37 | 0.43 | 0.48 | 0.53 |
DIVIDENDS PER SHARE | 0.14 | 0.16 | 0.16 | 0.19 | 0.21 |
DIVIDEND YIELD IN % | 1.83 % | 1.86 % | 1.81 % | - | - |
DIVIDEND GROWTH IN % | 144.63 % | 17.97 % | -1.00 % | - | - |
PRICE - EARNINGS RATIO | 29.23 | 23.64 | 20.67 | 18.06 | 16.48 |
PRICE - BOOK RATIO | 1.80 | 2.13 | 2.04 | - | - |
PRICE - SALES RATIO | 2.71 | 3.05 | 3.14 | - | - |
PRICE - CASH FLOW RATIO | 17.80 | 16.99 | 14.81 | - | - |
Master Data
| WKN | A3DNV1 |
| ISIN | US4055521003 |
| SYMBOL | H6D |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | HALEON PLC ADR O.N. |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 1.79 % | 12.50 % | 7.55 % | -2.29 % | 4.91 % | 11.76 % | - | 1.18 % |
| HIGH | 8.85 | 8.85 | 8.85 | 9.55 | 9.55 | 10.10 | - | 9.55 |
| LOW | 8.30 | 7.50 | 7.25 | 7.25 | 7.25 | 6.95 | - | 7.25 |
Dividende
pro Aktie
Company profile
Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm, and Asia Pacific. The company was founded on July 18, 2022 and is headquartered in Weybridge, the United Kingdom.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.